Alector to host virtual key opinion leader event on frontotemporal dementia on june 11, 2021

South san francisco, calif., may 26, 2021 (globe newswire) -- alector, inc. (nasdaq: alec), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that it will host a virtual key opinion leader event focused on frontotemporal dementia due to a progranulin gene mutation (ftd-grn) on friday, june 11, 2021 at 10:30 a.m. et.

ALEC Ratings Summary

ALEC Quant Ranking